引用本文:巩鹏,王忠裕,刘岳,王洪江,李冰,殷朔,李克军,赵荣宇.乌司他丁对恶性梗阻性黄疸术后并发症的防治[J].大连医科大学学报,2004,26(2):.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载  
分享到: 微信 更多
乌司他丁对恶性梗阻性黄疸术后并发症的防治
巩鹏1, 王忠裕1, 刘岳2, 王洪江1, 李冰1, 殷朔1, 李克军1, 赵荣宇1
1.大连医科大学,第一临床学院,普外科,辽宁,大连,116011;2.营口市第二人民医院,外一科,辽宁,营口,11500
摘要:
探讨乌司他丁(Ulinastatin,UTI)对恶性梗阻性黄疸病人术后并发症的防治作用及作用机理。[方法]对1990年1月~2002年3月恶性梗阻性黄 疸行胆肠吻合术及胰十二指肠切除术的198例病人术后每日消化液量、严重并发症及细胞因 子水平等作回顾性分析总结。[结果]术后1周内,平均消化液量为: 乌司他丁治疗组 72(例)胃液(324±53), 胆汁(296±43) ,胰液(164±10)mL/d,生长抑素治疗 组76(例)胃液(258±46) , 胆汁(201±35) ,胰液(40±8)mL/d,对照组50 (例) 胃液(744±60),胆汁(329±50),胰液(254±17)mL/d。乌司他丁治疗组 明 显少于对照组(P<0.01)。在198例病人中出现各种并发症76例,发生率为38.38% (76/19 8)。 乌司他丁治疗组并发症20例,发生率27.78%(20/72),对照组24例,发生率48.0%(24/5 0),乌司他丁治疗组明显低于对照组(χ 2=5.44,P<0.025)。乌司他丁治疗组胰 瘘总发生率为9.7%(7/72);对照组胰瘘总发生率为发生率为16.0%(8/50),乌司 他丁治疗组 胰瘘的发生率,明显低于对照组(χ2=6.63,P≤0.01),但与生长抑素治疗组无 显著性差 异(P>0.05)。术后第3、5天血清白细胞介素6(IL-6)、白细胞介素8(IL-8)及肿瘤 坏死 因子α(TNFα)水平乌司他丁治疗组明显低于生长抑素组(P<0.01)。[结论]乌司他 丁通 过减少各种消化液量及消化酶的浓度、降低促炎细胞因子水平及保护脏器功能的作用,有效 地防治恶性梗阻性黄疸术后并发症的发生。
关键词:  乌司他丁  梗阻性黄疸  并发症  细胞因子  防治
DOI:10.11724/jdmu.2004.02.07
分类号:R657.43
基金项目:辽宁省大连市科技计划
Prevention and cure effect of Ulinastatin on complications postoperation of malignant obstructive jaundice
GONG Peng,WANG Zhong-yu,LIU Yue,WANG Hong-jiang,LI Bing,YIN Shuo,LI Ke-jun,ZHAO Rong-yu
Department of General Surgery,the First Clinical College of Dalian Medical U niversity,Dalian 116011, China
Abstract:
To study the prevention and cure effect of Ulin as tatin on the complications postoperation of malignant obstructive jaundice and its mechanism . [Methods] The dose of daily digestive juice、the i ncidence rate of severe complication and the level of cytokine of 198 patients diagnosised m alignant obstructive jaundice performed by gallbladder jejunal anastomy and pancreaticoduodenectomy i n our hospital from January 1990 to March 2003 were reviewed retrospectively. [ Results] One hundred and ninetyeight cases were divided into 3 teams,team placebo 、team Ulin astatin and team somatost atin. The average dose of digestive juice in team Ulinastatin after a week blo od were gastric juice (324±53)mL,bile (296±43)mL and pancreatic fluid (164±10)mL. The average dose of team Ulinastatin, 27.78%(20/72) was remar kable lower than that in team placebo (P<0.01).The incidence of postoperati ve comp lications in team Ulinastatin, 27.78%(20/72)was remarkable lower than that in team placebo (48.0%,24/50,P<0.01). The level of blood serum interleukin 6 (IL- 6)、interleukin 8(IL-8)and tumor necrosis factor alpha(TNFα)were remarkable lower than that in team somatostatin. [Conclusion] Ulinastatin could effectively prevent and cure to postoperative complications of malignant obstructive jaun dice through lessening excretion dose and concentration of pancreatic juice and reducing cytokine.
Key words:  malignant obstructive jaundice  Ulinastatin(UTI)  treatment  complication  cytokine